DOCSLIB.ORG

Quantitative Assessment of the Effect of Pre-Gestational Diabetes and Risk of Adverse Maternal, Perinatal and Neonatal Outcomes

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Quantitative Assessment of the Effect of Pre-Gestational Diabetes and Risk of Adverse Maternal, Perinatal and Neonatal Outcomes www.impactjournals.com/oncotarget/ Oncotarget, 2017, Vol. 8, (No. 37), pp: 61048-61056 Research Paper Quantitative assessment of the effect of pre-gestational diabetes and risk of adverse maternal, perinatal and neonatal outcomes Lei Yu1,*, Xiao-Ling Zeng1,2,*, Ming-Liang Cheng3, Guo-Zhen Yang1, Bi Wang1,4, Zi-Wen Xiao1, Xin Luo2, Bao-Fang Zhang3, De-Wei Xiao4, Shuai Zhang5, Hua-Juan Liu3, Ya-Xin Hu3, Hou-Kang Lei1, Qin-Fen Li1 and Zheng-Rong Wang1 1Prenatal Diagnosis Center, Hospital Affiliated to Guizhou Medical University, Guiyang 550004, Guizhou, China 2The First Affiliated Hospital of Jinan University, Guangdong 510632, Guangzhou, China 3Department of Infectious Diseases, Hospital Affiliated to Guizhou Medical University, Guiyang 550004, Guizhou, China 4Department of Eugenics and Genetics, Guiyang Maternal and Child Health-Care Hospital, Guiyang 550003, Guizhou, China 5Department of Interventional Radiology, Cancer Hospital of Guizhou Medical University, Guiyang 550004, Guizhou, China *These authors have contributed equally to this work Correspondence to: Ming-Liang Cheng, email: [email protected] Guo-Zhen Yang, email: [email protected] Keywords: pre-gestational diabetes, adverse pregnancy outcomes, risk, meta-analysis Received: February 21, 2017 Accepted: April 05, 2017 Published: May 11, 2017 Copyright: Yu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Pregnancies complicated by pre-gestational diabetes (PGD) are associated with a higher rate of adverse outcomes, including an increased rage of preterm delivery, pregnancy-induced hypertension, pre-eclampsia, caesarean section, perinatal mortality, stillbirth, shoulder dystocia, macrosomia, small for gestational age, large for gestational age, low birth weight, neonatal hypoglycemia, neonatal death, low Apgar score, NICU admission, jaundice and respiratory distress. In the past two decades, numerous reports have been published regarding associations between PGD and risk of adverse outcomes. However, study results are inconsistent. To provide a synopsis of the current understanding of PGD for risk of adverse pregnancy outcomes, a random-effects meta-analysis over 40 million subjects from 100 studies was performed to calculate the pooled ORs. Potential sources of heterogeneity were systematically explored by multiple strata analyses and meta-regression. Overall, PGD were significantly associated with increased risk of preterm delivery (OR=3.48), LGA (OR=3.90), perinatal mortality (OR=3.39), stillbirth (OR=3.52), pre-eclampsia (OR=3.48), caesarean section (OR=3.52), NICU admission (OR=3.92), and neonatal hypoglycemia (OR=26.62). Significant results were also observed for 7 adverse outcomes with OR range from 1.54 to 2.82, while no association was found for SGA and respiratory distress after Bonferroni correction. We found that women with T1DM had higher risks for most of adverse pregnancy outcomes compared with women with T2DM. When stratified by study design, sample size, type of diabetes, geographic region, and study quality, significant associations remains. Our findings demonstrated that PGD is a strong risk- conferring factor for adverse maternal, perinatal and neonatal outcomes. INTRODUCTION diabetes (PGD) characterised by disturbance in glucose metabolism may be due to variable degrees of insulin Diabetes is one of the most common pre-existing resistance (type 2), or a consequence of autoimmune maternal disorders and complicated approximately 1.3% destruction of the pancreatic β-cells (type 1). With increasing of all pregnancies [1, 2]. Most women with pre-gestational numbers type 1 diabetes diagnosed among youth and high www.impactjournals.com/oncotarget 61048 Oncotarget prevalence of obesity among women of child-bearing age adverse pregnancy outcomes. Therefore, we conducted a [3–5], the demographic pattern of PGD is changing. Besides, comprehensive meta-analysis on all eligible studies to clarify the sex ratio of newly diagnosed type 2 diabetes among this inconsistency and to establish a comprehensive picture youth was remarkably skewed to female [6–8]. Therefore, of the relationship. continuous increase in diabetes rates in the global population will translate into higher prevalence of PGD eventually [9]. RESULTS Women with PGD are associated with adverse pregnancy outcomes. Unfortunately, the goal of the St. Characteristics of the included studies Vincent Declaration has not yet been achieved despite intensive maternal and neonatal care [10]. Furthermore, A detailed flowchart of literature search is shown PGD has also been associated with increased risk of maternal in Figure 1. We identified a total of 9650 citations from complications including shoulder dystocia, gestational the databases and 2 from reference lists. After exclusion hypertension, and pre-eclampsia [11–13], making pre- of duplicate reports and studies that did not meet our pregnancy care particularly glycaemic control and obstetrical inclusion criteria, a total of 100 publications were finally interventions of great importance. More recent studies on included in this study. Main characteristics of the included PGD have reported various results: preterm delivery and studies were summarised in Supplementary Table 1. These stillbirth were still significantly increased in some studies [2, eligible studies were published between 1993 and 2017, 14, 15] despite good metabolic control, while other studies and included a total of 304,144 women with PGD and > [16–18] reported that PGD was no longer a significant 40 million non-diabetic populations. Almost all included factor. These conflicting results may be partly due to ethnic studies were conducted in developed country, including diversity, insufficient power, phenotypic heterogeneity, and 28 studies in the North American, 48 in Europe, 3 in East even publication biases [19]. Until now, no quantitative Asian, 11 in Oceania, 3 in Africa and 7 with subjects assessment has focused on PGD with the risk various recruited from Middle East. 62 summarized results by two- Figure 1: Flow diagram for selection and inclusion of studies. www.impactjournals.com/oncotarget 61049 Oncotarget by-two tables, whereas 38 reported adjusted risk estimates. 4.02, P<10-5). Furthermore, PGD conferred much higher As for methodological quality assessment, 47 studies were risk of requiring caesarean section (OR=3.52; 95%CI: awarded ≥ 7 points, and 30 studies were awarded 5 to 6 2.91-4.25, P<10-5). In vaginal deliveries, the risk of points, indicating that the quality of included studies were shoulder dystocia occurred in infants delivered by pre- of median-to-high quality. Almost all included studies gestational diabetic mothers was much higher than control recruited women with singleton pregnancy, and only two infants with an OR of 2.73 (95%CI: 2.12-3.52, P<10-5). studies included women with twin pregnancy. As for perinatal outcomes including macrosomia, LGA, SGA, LBW, stillbirth, perinatal mortality, and low Quantitative data synthesis Apgar scores, the risk for women with PGD giving birth to LGA babies was significantly higher than for women Figure 2 shows the summary OR estimates for without diabetes (OR=3.90; 95%CI: 3.42-4.46, P<10-5). adverse pregnancy outcomes comparing women with PGD Similarly, women with PGD were more likely to have a with non-diabetic population. macrosomic infant (OR=1.91; 95%CI: 1.74-2.10, P<10-5) The adverse maternal outcomes were preterm and low birth weight babies than controls (OR=1.54; 95% delivery, very early preterm delivery, shoulder dystocia, CI: 1.45-1.64, P<10-5). In contrast, the risk of delivering caesarean section, pregnancy-induced hypertension an SGA infant was 0.86 (95%CI: 0.77-0.96, P=0.007). (PIH) and pre-eclampsia. The risk of preterm delivery at Women with PGD were more likely to have stillbirth or before 37 weeks was 3.48 (95%CI: 3.06-3.96, P<10- (OR=3.52; 95%CI: 3.19-3.88, P<10-5); thus, perinatal 5), whereas the risk was 2.55 (95%CI: 2.21-2.94, P<10- mortality (OR=3.39; 95%CI: 3.02-3.81, P<10-5) risks for 5) for very early preterm delivery in women with PGD. infants of PGD mothers were also significantly higher than There was significant difference in maternal hypertensive in the nondiabetic population (Table 1). complications. Using a random-effects model, the pooled As for secondary neonatal outcomes, women with OR of PIH was OR=2.56 (95%CI: 2.04-3.21, P<10-5). In PGD were more likely than those of women without addition, mother with PGD have statistically significant diabetes to have neonatal hypoglycaemia (OR=26.62; association with pre-eclampsia (OR=3.48; 95%CI: 3.01- 95%CI: 15.37-46.11, P<10-5), neonatal death (OR=2.26; Figure 2: Meta-analysis with a random-effect model for the association between pre-gestational diabetes and adverse pregnancy outcomes. www.impactjournals.com/oncotarget 61050 Oncotarget Table 1: Associations of pre-gestational diabetes and adverse pregnancy outcomes Overall Cohort based study Non-Cohort based study No. of No. of No. of Outcomes datasets datasets datasets OR (95%CI) P(Z) P(Q) OR (95%CI) P(Z) P(Q) OR (95%CI) P(Z) P(Q) Preterm delivery (< 37 weeks) 55 3.48 (3.06-3.96) <10-5 <10-5 21 3.69 (3.12-4.36) <10-5 <10-5 34 3.36 (2.85-3.96) <10-5 <10-5 Very early preterm delivery 4 2.55 (2.21-2.94) <10-5 0.22 4 2.55 (2.21-2.94) <10-5 0.22 NA NA NA NA (< 32 weeks)
Load more

Recommended publications
  • 14. Management of Diabetes in Pregnancy: Standards of Medical
    Diabetes Care Volume 42, Supplement 1, January 2019 S165 14. Management of Diabetes in American Diabetes Association Pregnancy: Standards of Medical Care in Diabetesd2019 Diabetes Care 2019;42(Suppl. 1):S165–S172 | https://doi.org/10.2337/dc19-S014 14. MANAGEMENT OF DIABETES IN PREGNANCY The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC. DIABETES IN PREGNANCY The prevalence of diabetes in pregnancy has been increasing in the U.S. The majority is gestational diabetes mellitus (GDM) with the remainder primarily preexisting type 1 diabetes and type 2 diabetes. The rise in GDM and type 2 diabetes in parallel with obesity both in the U.S. and worldwide is of particular concern. Both type 1 diabetes and type 2 diabetes in pregnancy confer significantly greater maternal and fetal risk than GDM, with some differences according to type of diabetes. In general, specific risks of uncontrolled diabetes in pregnancy include spontaneous abortion, fetal anomalies, preeclampsia, fetal demise, macrosomia, neonatal hypoglycemia, and neonatal hyperbilirubinemia, among others.
    [Show full text]
  • Neonatal Hypoglycemia in Diabetic Mothers: a Systematic Review Brook T
    Old Dominion University ODU Digital Commons Community & Environmental Health Faculty Community & Environmental Health Publications 2017 Neonatal Hypoglycemia in Diabetic Mothers: a Systematic Review Brook T. Alemu Old Dominion University Olaniyi Olayinka Old Dominion University, [email protected] Hind A. Baydoun Matthew oH ch Old Dominion University Muge Akpinar-Elci Old Dominion University, [email protected] Follow this and additional works at: https://digitalcommons.odu.edu/commhealth_fac_pubs Part of the Nutritional and Metabolic Diseases Commons Repository Citation Alemu, Brook T.; Olayinka, Olaniyi; Baydoun, Hind A.; Hoch, Matthew; and Akpinar-Elci, Muge, "Neonatal Hypoglycemia in Diabetic Mothers: a Systematic Review" (2017). Community & Environmental Health Faculty Publications. 25. https://digitalcommons.odu.edu/commhealth_fac_pubs/25 Original Publication Citation Alemu, B. T., Baydoun, H. A., Akpinar-Elci, M., Hoch, M., & Olayinka, O. (2017). Neonatal hypoglycemia in diabetic mothers: A systematic review. Current Pediatric Research, 21(1), 42-53. This Article is brought to you for free and open access by the Community & Environmental Health at ODU Digital Commons. It has been accepted for inclusion in Community & Environmental Health Faculty Publications by an authorized administrator of ODU Digital Commons. For more information, please contact [email protected]. Curr Pediatr Res 2017; 21 (1): 42-53 ISSN 0971-9032 www.currentpediatrics.com Neonatal hypoglycemia in diabetic mothers: A systematic review. Brook T Alemu1, Olaniyi Olayinka1, Hind A Baydoun2, Matthew Hoch1, Muge Akpinar Elci1 1Old Dominion University, College of Health Sciences, Norfolk, VA, USA. 2Department of Hospital Medicine, Johns Hopkins University School of Medicine, Baltimore, USA. Abstract Hypoglycemia occurs in approximately 8-30% of neonates born to mothers with diabetes.
    [Show full text]
  • Population-Based Study on Birth Outcomes Among Women
    www.nature.com/scientificreports OPEN Population‑based study on birth outcomes among women with hypertensive disorders of pregnancy and gestational diabetes mellitus Ya‑Wen Lin1,2, Ming‑Hung Lin3, Lee‑Wen Pai4, Jen‑Wei Fang5, Chih‑Hsin Mou6, Fung‑Chang Sung6,7,8,10 & Ya‑Ling Tzeng1,9,10* To evaluate birth outcomes in women with hypertensive disorders of pregnancy (HDP) and gestational diabetes mellitus (GDM), we used insurance data of Taiwan to evaluate 11 adverse neonatal outcomes of infants born to women with HDP (N = 7775) and with both HDP and GDM (HDP/GDM) (N = 1946), comparing to women with neither disorder (N = 19,442), matched by age. The impacts of preeclampsia/eclampsia were also evaluated. Results showed that Caesarean section delivery was near 1.7‑fold greater in the HDP/GDM and HDP groups than in comparisons. The preterm delivery rates were more than threefold greater in HDP/GDM group and HDP group than in comparisons with adjusted odds ratios (aORs) of 4.84 (95% confdence interval (CI) 4.34–5.40) and 3.92 (95% CI 3.65– 4.21), respectively, followed by jaundice (aORs 2.95 (95% CI 2.63–3.33) and 1.90 (95% CI 1.76–2.06)), and small gestation age (SGA) (aORs 6.57 (95% CI 5.56–7.75) and 5.81 (95% CI 5.15–6.55)). Incidence rates of birth trauma, patent ductus arteriosus, atrial septal defect, respiratory distress syndrome, and neonatal hypoglycemia were also higher in the HDP/GDM and HDP groups than in the comparison group.
    [Show full text]
  • Pumps Or Multiple Daily Injections in Pregnancy Involving Type 1 Diabetes
    Diabetes Care Volume 41, December 2018 2471 Denice S. Feig,1,2,3 Rosa Corcoy,4,5 Pumps or Multiple Daily Injections Lois E. Donovan,6 Kellie E. Murphy,1,2,3 CLIN CARE/EDUCATION/NUTRITION/PSYCHOSOCIAL Jon F.R. Barrett,7 J. Johanna Sanchez,7 in Pregnancy Involving Type 1 Tim Wysocki,8 Katrina Ruedy,9 fi Craig Kollman,9 George Tomlinson,3,10 and Diabetes: A Prespeci ed Analysis Helen R. Murphy,11,12,13 on behalf of the of the CONCEPTT Randomized CONCEPTT Collaborative Group* Trial Diabetes Care 2018;41:2471–2479 | https://doi.org/10.2337/dc18-1437 OBJECTIVE 1Mount Sinai Hospital, Sinai Health System, To compare glycemic control, quality of life, and pregnancy outcomes of women Toronto, Ontario, Canada 2Lunenfeld-Tanenbaum Research Institute, Tor- using insulin pumps and multiple daily injection therapy (MDI) during the onto, Ontario, Canada Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy 3Department of Medicine, University of Toronto, Trial (CONCEPTT). Toronto, Ontario, Canada 4Hospital de la Santa Creu i Sant Pau, Barcelona, RESEARCH DESIGN AND METHODS Spain 5 fi CIBER-BBN, Zaragoza, Spain This was a prespeci ed analysis of CONCEPTT involving 248 pregnant women from 6University of Calgary, Calgary, Alberta, Canada 7 31 centers. Randomization was stratified for pump versus MDI and HbA1c. The Sunnybrook Research Institute, Toronto, On- primary outcome was change in HbA1c from randomization to 34 weeks’ gestation. tario, Canada 8 ’ Key secondary outcomes were continuous glucose monitoring (CGM) measures, Nemours Children s Health System, Jacksonville, FL maternal-infant health, and patient-reported outcomes.
    [Show full text]
  • Identifying Risk Effectors Involved in Neonatal Hypoglycemia Occurrence
    Bioscience Reports (2020) 40 BSR20192589 https://doi.org/10.1042/BSR20192589 Research Article Identifying risk effectors involved in neonatal hypoglycemia occurrence Tian Zhao*, Qiying Liu*, Man Zhou, Wei Dai, Yin Xu, Li Kuang, Yaqiong Ming and Guiyu Sun Department of Obstetrics, Guizhou Provincial People’s Hospital, Guizhou 550002, China Correspondence: Guiyu Sun ([email protected]) Hypoglycemia is a common metabolic condition in neonatal period, but severe and persis- tent hypoglycemia can cause neurological damage and brain injury. The aim of the present study was to analyze the risk factors of neonatal hypoglycemia in clinic. A total of 135 neona- tal hypoglycemia infants and 135 healthy infants were included in the present study. The differences in birth weight between neonatal hypoglycemia group and healthy control group were analyzed via t test. The associations between neonatal blood sugar level and relevant characteristic factors were explored using χ2 test. Binary logistic regression analysis was used to analyze risk factors related to the incidence of neonatal hypoglycemia. The results showed that the average birth weight was matched in neonatal hypoglycemia group and healthy control group. Neonatal blood sugar level of the infants was significantly associated with born term, birth weight, feed, gestational diabetes mellitus (GDM) and hypothermia (all P<0.05). Besides, logistic regression analysis showed that babies’ born term (odds ratio (OR) = 2.715, 95% confidence interval (95% CI): 1.311–5.625), birth weight (OR = 1.910, 95% CI: 1.234–2.955), improper feeding (OR = 3.165, 95% CI: 1.295–7.736) and mother’s GDM (OR = 2.184, 95% CI: 1.153–4.134) were high risk factors for neonatal hypoglycemia.
    [Show full text]
  • Materno-Fetal and Neonatal Complications of Diabetes
    Journal of Clinical Medicine Article Materno-Fetal and Neonatal Complications of y Diabetes in Pregnancy: A Retrospective Study Giampiero Capobianco 1,* , Alessandra Gulotta 1, Giulio Tupponi 1, Francesco Dessole 1, Maddalena Pola 1, Giuseppe Virdis 1, Marco Petrillo 1, Valerio Mais 2 , Giorgio Olzai 3, Roberto Antonucci 4, Laura Saderi 5 , Pier Luigi Cherchi 1, Salvatore Dessole 1 and Giovanni Sotgiu 5 1 Gynecologic and Obstetric Clinic, Department of Medical, Surgical and Experimental Sciences, University of Sassari, 07100 Sassari, Italy; [email protected] (A.G.); [email protected] (G.T.); [email protected] (F.D.); [email protected] (M.P.); [email protected] (G.V.); [email protected] (M.P.); [email protected] (P.L.C.); [email protected] (S.D.) 2 Gynecologic and Obstetric Clinic, University of Cagliari, 09121 Cagliari, Italy; [email protected] 3 Neonatal Intensive Care Unit (NICU), Sassari University, 07100 Sassari, Italy; [email protected] 4 Pediatric Clinic, Sassari University, 07100 Sassari, Italy; [email protected] 5 Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, 07100 Sassari, Italy; [email protected] (L.S.); [email protected] (G.S.) * Correspondence: [email protected]; Tel.: +39-3392-897-821; Fax: +39-079-228-265 Condensation: Retrospective study on materno-foetal and neonatal complications of diabetes in pregnancy. y Received: 5 July 2020; Accepted: 19 August 2020; Published: 21 August 2020 Abstract: The aim of this case–control study was to evaluate maternal–fetal and neonatal clinical outcomes in a group of patients with gestational diabetes mellitus (GDM) and pregestational diabetes such as diabetes mellitus type 1 (DM1) and diabetes mellitus type 2 (DM2) and compare them with those of patients without diabetes.
    [Show full text]
  • Glycemic Targets in the Second and Third Trimester of Pregnancy for Women with Type 1 Diabetes
    Page 1 of 30 Diabetes Care Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes Short title: Pregnancy glycemic targets in type 1 diabetes Authors: Michael J.A. Maresh, MD1, Valerie A. Holmes, PhD2, Christopher C. Patterson, PhD2, Ian S. Young, MD2, Donald W.M. Pearson, MD3, James D. Walker, MD4, David R. McCance, MD5; For the Diabetes and Pre-eclampsia Intervention Trial Study Group 1. Department of Obstetrics, St Mary’s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK 2. Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast, UK 3. Department of Diabetes, Aberdeen Royal Infirmary, Aberdeen, UK; 4. Department of Diabetes, St John’s Hospital at Howden, West Lothian, UK 5. Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, UK Corresponding author:- Dr MJA Maresh, Department of Obstetrics, St Mary’s Hospital, Oxford Road, Manchester M13 9WL Tel: 0044 161 276 6426 Fax 0044 161 276 6426 Email : [email protected]. Word count: 3893 Tables: 4 Diabetes Care Publish Ahead of Print, published online November 3, 2014 Diabetes Care Page 2 of 30 Abstract Objective To assess the relationship between second and third trimester glycemic control and adverse outcomes in pregnant women with type 1 diabetes, as uncertainty exists about optimum glycemic targets. Research Design and Methods Pregnancy outcomes were assessed prospectively in 725 women with Type 1 diabetes from the Diabetes and Pre-eclampsia Intervention Trial. HbA1c (A1C) values at 26 and 34 weeks’ gestation were categorised into 5 groups; the lowest, <6.0% (42mmol/mol), being the reference.
    [Show full text]